MDMA interactions with pharmaceuticals and drugs of abuse Autor: Papaseit E, Pérez-Mañá C, Torrens M, Farré A, Poyatos L, Hladun O, Sanvisens A, Muga R, Farré M. Revista: Expert Opin Drug Metab Toxicol. 2020 May;16(5):357-369. Epub 2020 Apr 12. Fuente: Expert Opin...
Cocaine and depressive disorders: When standard clinical diagnosis is insufficient Autor: Alías-Ferri M, García-Marchena N, Mestre-Pintó JI, Araos P, Vergara-Moragues E, Fonseca F, González-Saiz F, Rodríguez de Fonseca F, Torrens M, Group N. Revista: Adicciones. 2020...
Acute Effects of 2C-E in Humans: An Observational Study Autor: Papaseit E, Olesti E, Pérez-Mañá C, Torrens M, Grifell M, Ventura M, Pozo OJ, de Sousa Fernandes Perna EB, Ramaekers JG, de la Torre R, Farré M. Revista: Front Pharmacol. 2020 Mar 18;11:233. eCollection...
Safety of nalmefene for the treatment of alcohol use disorder: an update Autor: López-Pelayo H, Zuluaga P, Caballeria E, Van den Brink W, Mann K, Gual A. Revista: Expert Opin Drug Saf. 2020 Jan;19(1):9-17 Fuente: Expert Opinion on Drug Safety Volver a...
Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment Autor: García-Calvo X, Bolao F, Sanvisens A, Zuluaga P, Tor J, Muga R, Fuster D. Revista: Alcohol Clin Exp Res....
Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles > GIAS | 2019 | Publicaciones Autor: Fuster D, Gelberg L En: J Community Health. 2019 Dec;44(6):1044-1054. Fuente: Journal of...
